Investor Relations

Stay Informed with BrainChipTM Investor Resources

Corporate Overview

BrainChip is the worldwide leader in edge AI on-chip processing and learning. The company’s first-to-market neuromorphic processor, Akida™, mimics the human brain to analyze only essential sensor inputs at the point of acquisition, processing data with unparalleled efficiency, precision, and economy of energy. Keeping machine learning local to the chip, independent of the cloud, also dramatically reduces latency while improving privacy and data security.

BrainChip enables effective edge compute to be universally deployable across real-world applications such as connected cars, consumer electronics, and industrial IoT.

BrainChip is proving that on-chip AI, close to the sensor, is the future for its customers’ products and the planet.

Latest Investor Presentation
BrainChip, Inc.

Why Invest

Electronic Shareholder Communications

Learn how to receive your shareholder communications electronically for faster access to company updates, reports, and announcements—delivered directly to your inbox in a secure, paperless format.

Managing your shares

Login to the Boardroom share registry site to view information about your BRN shares. Boardroom can be contacted by emailing enquiries@boardroomlimited.com.au or by phone on 1300 737 760 (within Australia) or +61 2 9290 9600 (internationally).

BrainChip AGM 2024 - Recorded Webcast

The Brainchip 2024 AGM was held in Sydney on 21 May 2024. Watch a recording of the AGM here, including the CEO & CTO presentations, the Q&A with shareholders and the voting procedures for the business of the meeting.

Stocks Down Under: Post AGM interview with CEO Sean Hehir

We spoke with Sean Hehir, CEO of BrainChip (ASX:BRN), after the company’s AGM to get the key takeaways from the AGM and to see where BrainChip is at with respect to signing additional commercial deals!

Market announcements - BRN

Access the official website of the Australian Securities Exchange (ASX) to explore important updates, news releases, and financial information regarding BrainChip, Inc (BRN).

Receiving your shareholder communications electronically is the best way to stay informed and will assist BrainChip with minimizing paper usage. If you haven’t already, we encourage you to make the switch to paperless communications and provide us with your email address.

To make the change, login to www.investorserve.com.au, add your email address via ‘My Details’ on the left-hand side of the screen and click ‘Communication Options’ to select the communication options you would like to set to email.

You can make a standing election as to how you would like to receive certain documents including annual reports, meeting-related documents (for example notices of meeting and proxy/voting forms) and payment statements.

You can also make a one-of request to receive a document in physical or electronic form by contacting the registry on enquiries@boardroomlimited.com.au.

You will also be able to access Shareholder Documents such as our Annual Report, Notice of Meeting and other documents relating to shareholder meetings when they are published on our website or made available on the ASX platform.

Our stock is traded on the ASX under the symbol BRN and BCHPY and BRCHF on the OTCQX Market.
BRCHF common shares are traded OTC on the OTCQX.
In Australia July 2004, in USA December 2013.
BrainChip Holdings Ltd was listed on ASX in November 2011 and merged with BrainChip Inc.and was reinstated on ASX in September 2015.

BrainChip Inc
23041 Avenida De La Carlota #250
Laguna Hills CA 92653
T 949.784.0040
F 949.784.0050

BrainChip Holdings Ltd
Level 12 225 George St Sydney NSW 2000 AU
T 61.2.8016.2841

BrainChip Research Institute
Level 2 / 182 St George’s Terrace, Perth, Western Australia 6000 Australia
T 61.8.8600.9662

BrainChip SAS
8 Rue Henri Jansou 31200 Toulouse France
T 33.5.6100.9145

Brainchip Systems India Pvt Ltd
H. No: 6-3-1090/B/4
5th Floor, North-East Corner, Rajbhavan Road, Hyderabad, Telangana, India 500082
T 91.98.494.78130

BrainChip’s fiscal year ends December 31st

HLB Mann Judd (WA Partnership) Level 4, 130 Stirling
Street 6000 Australia
Phone:+618 9227 7500
Web: www.hlb.com.au

Boardroom Pty Limited
Level 12, 225 George St Sydney NSW 2000
GPO Box 3993 Sydney NSW2001
Phone: (02)92909600
Fax: (02)92790664
enquiries@boardroomlimited.com.au
boardroomlimited.com.au

Maddock’s Angel Place, Level 27, 123 Pitt Street, Sydney NSW 2000 Australia
Telephone:+612 9291 6197

Pillsbury Winthrop Shaw Pittman LP
Four Embarcadero Center, 22nd Floor, San Francisco, CA 94111
Phone:+1(415)983-1540

Tony Dawe
Director, Global Investor Relations
ir@brainchip.com

BrainChip’s Level I ADRs are traded in the US on the OTCQX over-the-counter market under the ticker BCHPY

Depositary receipts (DRs) are negotiable U.S. securities issued by a U.S. bank, referred to as a “depositary bank,” that typically represent a non-U.S. company’s equity. DRs trade freely in global markets and facilitate cross-border trading.

DRs allow non-U.S. companies to make their shares available outside their home markets and allow investors in the U.S. and elsewhere to easily invest in companies on a more global basis.

Investors in the United States can benefit from holding ADRs rather than ordinary shares in the issuer’s home market, because ADRs trade, clear and settle according to United States market conventions.ADRs allow US investors to diversify into non-US securities and hold these in their US brokerage accounts. ADRs also allow easy comparison to securities of similar companies as well as access to price and trading information, U.S. dollar dividend payments and corporate action notifications.

BNY Mellon is the depositary bank and plays a key role in the process of issuance andcancellation of ADRs.
For more information, please visit:

www.adrbnymellon.com
www.adrbnymellon.com/resources/dr-basics

An ADR ratio provides the number of underlying shares represented by one ADS. 1 BrainChip ADR represents 40 ordinary BRN shares on the Australian Securities Exchange (ASX). The two securities trade very close to parity once the ADR ratio and foreign exchange aspects are accounted for.

An ADR isa negotiable certificate issued by a depositary bank to represent a specific number of shares of a foreign company traded on a U.S. exchange. An ADS (American Depositary Share) is the share issued under the ADR agreement which is actually traded.

BrainChip ADRs can be purchased through a typical broker, just as you would to buy U.S. securities. You cannot buy ADRs directly from BrainChip.

Converting ordinary shares into ADRs can be done through an investment advisor or broker.To convert your ordinary shares into ADRs:

  1. ‍You need to transfer your ordinary BRN shares to BNY Mellon’s local custodian, HSBC Bank Australia Limited (BIC: HKBAAU2SSYD, CHESS PID: 20057, safekeeping account: 011-552130-068). This process is usually completed by your broker via a broker transfer form.
  2. Once BNY Mellon receives confirmation that your underlying ordinary shares have been deposited with HSBC, new ADRs are issued and delivered to your nominated US broker, in accordance with the ADR programs “Deposit Agreement”. A copy can be found by visiting: Click here Contact BNY Mellon for additional assistance. (E-mail adrdesk@bnymellon.com)

ADR issuers generally have full information in English about themselves on their websites. ADRs listed on U.S. exchanges provide holders with the same level of information as any other U.S. security with trading information readily available. Please visit BrainChip’s shareholder site to find further information including annual reports, quarterly updates, investor presentations and market announcements.

A registered holder is one whose name appears on the books of the depositary. The registered holder is considered the owner of the record. A beneficial holder is one whose holdings are registered in a name other than his or her own, such as the name of the broker, bank, or nominee.

For registered owners, ownership is registered by the depositary bank and is evidenced by an account statement provided by the depositary. Registered owners can hold physical ADR certificates.
Please contact BNY Mellon for more information.
For additional questions about ADRs please contact: BNY Mellon Shareowner Services
P. O. Box 505000
Louisville, KY 40233-5000
U.S. Toll Free Telephone: 1-888-BNY-ADRS (1-888-269-2377)
Telephone for International Callers: 1-201-680-6825
Website: www.mybnymdr.com
E-Mail: shrrelations@cpushareownerservices.com

A registered holder is one whose name appears on the books of the depositary. The registered holder is considered the owner of the record. A beneficial holder is one whose holdings are registered in a name other than his or her own, such as the name of the broker, bank, or nominee.

Shareholder Communications

Receiving your shareholder communications electronically is the best way to stay informed and will assist BrainChip with minimising paper usage. If you haven’t already, we encourage you to make the switch to paperless communications and provide us with your email address. To make the change, login to www.investorserve.com.au, add your email address via ‘My Details’ on the left-hand side of the screen and click ‘Communication Options’ to select the communication options you would like to set to email.
You can make a standing election as to how you would like to receive certain documents including annual reports, meeting-related documents (for example notices of meeting and proxy/voting forms) and payment statements. You can also make a one-off request to receive a document in physical or electronic form by contacting the registry on enquiries@boardroomlimited.com.au.
You will also be able to access Shareholder Documents such as our Annual Report, Notice of Meeting and other documents relating to shareholder meetings when they are published on our website or made available on the ASX platform.

Stay Updated with Investor Alerts

Never miss an important update. Sign up to receive email alerts about BrainChip latest investor news, ASX announcements, financial reports, and company updates—delivered directly to your inbox.

Episode 7 - BrainChip Investor Podcast Q2 2024

In this seventh episode of BrainChip’s Investor Podcast Series, Director of Global Investor Relations Tony Dawe presents questions to Hehir across a range of topics including recent company developments, sales wins, commercialization strategy, and other various matters of shareholder interests.

Episode 6 - BrainChip Investor Podcast Q2 2024

In the latest episode of BrainChip’s Quarterly Investor Podcast, CEO Sean Hehir discusses recent company developments, including a recap of the Annual General Meeting, updates on the new executive management and Scientific Advisory Board members, and the additional funding raised. The podcast also highlights the company’s focus on advancing Akida 2.0 and TENNs technologies. Tune in for an in-depth discussion on BrainChip’s progress and future direction.

Episode 5 – BrainChip Investor Podcast Q1 2024

Explore the latest insights into BrainChip’s developments and initiatives in the Quarterly Investor Podcast Episode 5. Join CEO Sean Hehir as he discusses shareholder-focused topics such as the Akida™ SpaceTech launch milestone, Embedded World Conference recap, Akida Edge AI Box update, and insights into proxy advisors, put option agreements, and investor engagement. Tune in for an informative discussion on BrainChip’s progress and shareholder interests.

February 27, 2024 Virtual Investor Podcast

In this Investor Podcast, BrainChip CEO Sean Hehir provides an update to shareholders and potential investors on the execution of the company’s commercial strategy, the recent CES2024 event in Las Vegas, where BrainChip demonstrated some of its next-generation neuromorphic technology products. The podcast introduces newly appointed CTO Dr. Tony Lewis, and includes a discussion of upcoming neuromorphic product rollouts, and respond to questions from shareholders.

Episode 4 – BrainChip Investor Podcast Q4 2023

In this fourth episode of BrainChip’s Quarterly Investor Podcast, CEO Sean Hehir answers questions from BrainChip’s investors and potential investors, as well as provides highlights from CES (Consumer Electronics Show) 2024, recaps many of the successes of the company in 2023 and shares exciting activities and events coming this year.‍

Episode 3 – BrainChip Investor Podcast Q3 2023

In the latest episode of our investor podcast, BrainChip CEO Sean Hehir tackles questions from investors with Tony Dawe, Director of Global Investor Relations for BrainChip. Tune in to hear BrainChip’s strategic direction, investment, execution, and progress that also addresses questions close to investor’s hearts, about the stock price, transparent communications and more.‍

Episode 2 – BrainChip Investor Podcast Q2 2023 (Part 2)

Part 2 covers Viana’s responses about the transition from and R&D company developing chips to an AI chip design company licensing IP, share price, the product roadmap, market prospects, and much more.

Episode 2 – BrainChip Investor Podcast Q2 2023 (Part 1)

BrainChip Board Chair Antonio J. Viana responded to investor-submitted questions in our Q2 investor podcast hosted by Director of Global Investor Relations Tony Dawe. In Part 1, Viana gave his frank views on such hot-button topics as global reporting and ESG considerations, changes in remuneration and stock compensation since the AGM, execution of the commercialization strategy for the Akida™ platform and the state of the global AI sector and its impact on BrainChip customers.

Quarterly Investor Podcast - Q1 April 2023

In this inaugural episode, BrainChip’s CEO Sean Hehir and Director of Global Investor Relations Tony Dawe original Akida, the 2nd Generation platform, the company’s business model and engagement cycle, and what investors stand to gain as part of the BrainChip ecosystem.‍